Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 814 Records) |
| Query Trace: Neoplasms and APC[original query] |
|---|
| Determination of the frequency and distribution of APC, PIK3CA, and SMAD4 gene mutations in Ugandan patients with colorectal cancer. BMC cancer 2024 9 24 (1): 1212. Richard Wismayer, Rosie Matthews, Celina Whalley, Julius Kiwanuka, Fredrick Elishama Kakembo, Steve Thorn, Henry Wabinga, Michael Odida, Ian Tomlins |
| Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer. NPJ precision oncology 2024 9 8 (1): 214. Jingyuan Wang, Joanne Xiu, Francesca Battaglin, Hiroyuki Arai, Shivani Soni, Wu Zhang, Richard M Goldberg, Philip A Philip, Andreas Seeber, Jimmy J Hwang, Anthony F Shields, John L Marshall, Igor Astaturov, Tianshu Liu, A Craig Lockhart, W Michael Korn, Lin Shen, Heinz-Josef Le |
| Molecular genetic analysis of colorectal carcinoma with an aggressive extraintestinal immunohistochemical phenotype. Scientific reports 2024 9 14 (1): 22241. Jan Hrudka, Markéta Kalinová, Hana Fišerová, Karolína Jelínková, Andrej Nikov, Petr Waldauf, Radoslav Mat |
| Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study. International journal of clinical oncology 2024 9 . Shunsuke Kasai, Hiroyasu Kagawa, Keiichi Hatakeyama, Akio Shiomi, Shoichi Manabe, Yusuke Yamaoka, Yusuke Tanaka, Takahiro Igaki, Takeshi Nagashima, Keiichi Ohshima, Kenichi Urakami, Yasuto Akiyama, Yusuke Kinugasa, Ken Yamaguc |
| Combined KRAS and TP53 mutation in patients with colorectal cancer enhance chemoresistance to promote postoperative recurrence and metastasis. BMC cancer 2024 9 24 (1): 1155. YiMeng Tang, Yao F |
| The coexistence of a BRCA2 germline and a DICER1 somatic variant in two first-degree cousins suggests their potential synergic effect. Scientific reports 2024 9 14 (1): 21435. Giada Del Baldo, Angela Mastronuzzi, Selene Cipri, Emanuele Agolini, Marta Matraxia, Antonio Novelli, Antonella Cacchione, Annalisa Serra, Andrea Carai, Luigi Boccuto, Giovanna Stefania Colafati, Pier Luigi Di Paolo, Evelina Miele, Sabina Barresi, Rita Alaggio, Sabrina Rossi, Isabella Giovanno |
| Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival. JAMA oncology 2024 9 . Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, Mohammad M Fanaeian, Mark Knafl, Jennifer Peterson, Mohammad Zeineddine, Kristin Alfaro, Fadl Zeineddine, Drew Goldstein, Nicholas Hornstein, Arvind Dasari, Ryan Huey, Benny Johnson, Victoria Higbie, Alisha Bent, Bryan Kee, Michael Lee, Maria Pia Morelli, Van Karlyle Morris, Daniel Halperin, Michael J Overman, Christine Parseghian, Eduardo Vilar, Robert Wolff, Kanwal P Raghav, Michael G White, Abhineet Uppal, Ryan Sun, Wenyi Wang, Scott Kopetz, Jason Willis, John Paul Sh |
| Mutation patterns in colorectal cancer and their relationship with prognosis. Heliyon 2024 9 10 (17): e36550. Zhaoran Su, Maria El Hage, Michael Linnebach |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer genomics & proteomics 2024 8 21 (5): 448-463. Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgia Pepe, Dimitra Bouzarelou, Athanasios Papathanasiou, Dimitrios Grigoriadis, Georgios N Tsaousis, Helen Gogas, Theodore Troupis, Konstantinos Papazisis, Ioannis Natsiopoulos, Vassileios Venizelos, Kyriakos Amarantidis, Stylianos Giassas, Christos Papadimitriou, Elena Fountzilas, Maroulio Stathoulopoulou, Anna Koumarianou, Grigorios Xepapadakis, Alexandru Blidaru, Daniela Zob, Oana Voinea, Mustafa Özdo?an, Mahmut Çerkez Ergören, Alinta Hegmane, Eirini Papadopoulou, George Nasioulas, Christos Markopoul |
| Frequency of pathogenic germline variants in pediatric medulloblastoma survivors. Frontiers in oncology 2024 8 14 1441958. Donald Rees, D Matthew Gianferante, Jung Kim, Theodora Stavrou, Gregory Reaman, Yadav Sapkota, M Monica Gramatges, Lindsay M Morton, Melissa M Hudson, Gregory T Armstrong, Neal D Freedman, Wen-Yi Huang, W Ryan Diver, Adriana Lori, Wen Luo, Belynda D Hicks, Jia Liu, Amy A Hutchinson, Alisa M Goldstein, Lisa Mirabel |
| Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status. BMC pulmonary medicine 2024 8 24 (1): 407. Yoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, Daijiro Harada, Shun-Ichi Isa, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Atsuhisa Tamura, Masahiko Ando, Yasuhiro K |
| Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes. International journal of cancer 2024 12 . Pooja Mittal, Francesca Battaglin, Yasmine Baca, Joanne Xiu, Alex Farrell, Shivani Soni, Jae Ho Lo, Lesly Torres-Gonzalez, Sandra Algaze, Priya Jayachandran, Karam Ashouri, Alexandra Wong, Wu Zhang, Jian Yu, Lin Zhang, Benjamin A Weinberg, Emil Lou, Anthony F Shields, Richard M Goldberg, John L Marshall, Sanjay Goel, Indrakant K Singh, Heinz-Josef Le |
| Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT Database. Current issues in molecular biology 2024 12 46 (12): 14476-14486. Shuhei Suzuki, Yosuke Saito, Koki Saito, Yuta Yamada, Koshi Takahashi, Ryosuke Kumanishi, Tadahisa Fukui, Takashi Yoshio |
| IDENTIFICATION OF CLINICALLY RELEVANT GENE VARIANTS IN COLON ADENOCARCINOMA SAMPLES OF UKRAINIAN PATIENTS USING A COMPREHENSIVE CANCER PANEL: A PILOT STUDY. Experimental oncology 2024 12 46 (3): 221-227. G Gerashchenko, R Gulkovskyi, N Melnichuk, N Hryshchenko, T Marchyshak, O Mankovska, A Bezverkhiy, I Kotuza, L Rosha, A Kotuza, Z Tkachuk, V Kashuba, M Tuka |
| BRCA2 germline mutation carrier with five malignancies: a case report. Hereditary cancer in clinical practice 2024 12 22 (1): 27. Elena Su, Yann Christinat, Thomas McKee, Silvia Azzarello-Burri, Wolfram Jochum, Stefanie Fischer, Christian Rothermun |
| Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers. Communications medicine 2024 12 4 (1): 256. Reagan M Barnett, Albert Jang, Sree Lanka, PIngfu Fu, Leslie A Bucheit, Hani Babiker, Alan Bryce, Haley M Meyer, Yujin Choi, Casey Moore, Rohan Garje, Xin Gao, Dae Won Kim, Richard Y Chang, Pat Gulhati, Ryne Ramaker, Rani Bansal, Tian Zhang, A Oliver Sartor, Andrew J Armstrong, Mehmet A Bilen, Pedro Bara |
| Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay. BMC cancer 2024 12 24 (1): 1547. Mariana Bisarro Dos Reis, Wellington Dos Santos, Ana Carolina de Carvalho, Adhara Brandão Lima, Monise Tadin Reis, Florinda Santos, Rui Manuel Reis, Denise Peixoto Guimarã |
| Prevalence of the major thyroid cancer-associated syndromes in the United States. medRxiv : the preprint server for health sciences 2024 12 . Samantha L White, Taylor Jamil, Caitlin Bell, Lauren Fishbein, Bryan R Haugen, Christopher R Gignoux, Nikita Pozdey |
| Genomic mosaicism in colorectal cancer and polyposis syndromes: a systematic review and meta-analysis. International journal of colorectal disease 2024 12 39 (1): 201. Francisco Cezar Aquino de Moraes, Nayara Rozalem Moretti, Vitor Kendi Tsuchiya Sano, Cristiane Wen Tsing Ngan, Rommel Mario Rodríguez Burba |
| Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2. Gut 2024 11 . Vidya Rajasekaran, Bradley T Harris, Ruby T Osborn, Claire Smillie, Kevin Donnelly, Marion Bacou, Edward Esiri-Bloom, Li-Yin Ooi, Morven Allan, Marion Walker, Stuart Reid, Alison Meynert, Graeme Grimes, James P Blackmur, Peter G Vaughan-Shaw, Philip J Law, Ceres Fernández-Rozadilla, Ian Tomlinson, Richard S Houlston, Kevin B Myant, Farhat Vn Din, Maria Timofeeva, Malcolm G Dunlop, Susan M Farringt |
| Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer. Molecular cancer 2024 11 23 (1): 264. Luís Nunes, Jakob Mørkved Stenersen, Kushtrim Kryeziu, Tobias Sjöblom, Bengt Glimelius, Ragnhild A Lothe, Anita Sve |
| Adenomatous Polyposis Coli (APC) Promoter Gene Methylation in Urine-Derived DNA: A Non-invasive Biomarker for Early Bladder Cancer Detection and Tumor Aggressiveness. Cureus 2024 11 16 (10): e72055. Mouna Aqerrout, Imane Mharrach, Kaoutar Anouar Tadlaoui, Abdelilah Laraqui, Mohamed Rida Tagajdid, Khalid Ennibi, Moulay Mustapha Enna |
| The tissue and circulating cell-free DNA-derived genetic landscape of premalignant colorectal lesions and its application for early diagnosis of colorectal cancer. MedComm 2024 11 5 (12): e70011. Qingjian Chen, Yu-Hong Xu, Shiyang Kang, WuHao Lin, Linna Luo, Luping Yang, Qi-Hua Zhang, Pan Yang, Jia-Qian Huang, Xiaoni Zhang, Jing Zhang, Qi Zhao, Rui-Hua Xu, Hui-Yan L |
| LRP1B associated with immune cell infiltration influenced the efficacy of immunotherapy in colorectal cancer patients. Clinics (Sao Paulo, Brazil) 2024 11 79 100516. Weiming Weng, Shengquan He, Guoxiong Zhang, Xindong Zhou, Kang Li, Jiajun L |
| Genetic Testing of Japanese Patients with Serrated Polyposis Syndrome: A Multicentric Study. Journal of the anus, rectum and colon 2024 10 8 (4): 348-355. Akinari Takao, Tatsuro Yamaguchi, Hidetaka Eguchi, Yasushi Okazaki, Hideki Ishikawa, Kiwamu Akagi, Hideyuki Ishi |
| Cancer Risks in Attenuated and Classical Familial Adenomatous Polyposis: A Nationwide Cohort with Matched, Non-Exposed Individuals: Cancer and surgery in AFAP and FAP patients. The American journal of gastroenterology 2024 10 . Søren Hammershøj Beck, John Gásdal Karstensen, Steffen Bülow, Klaus Kaae Andersen, Thomas van Overeem Hansen, Helle Højen, Niels Jespersen, Tine Plato Kuhlmann, Hans Christian Pommergaard, Mads Damgaard Wewer, Laus Wullum, Anne Marie Jelsig, Johan Buris |
| Homologous recombination deficiency score is an independent prognostic factor in esophageal squamous cell carcinoma. The journal of pathology. Clinical research 2024 10 10 (6): e70007. Yulu Wang, Bowen Ding, Yunlan Tao, Lingli Huang, Qian Zhu, Chengying Gao, Mingli Feng, Yuchen H |
| CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
| Unveiling the role of KRAS in Chinese colorectal cancer patients: a positive influence on tumor mutational burden. Translational cancer research 2024 10 13 (9): 4752-4762. Xuebin Wan, Xiaoni Zhang, Mingyan Xu, Zhi Zheng, Yujun Zhou, Zhiyong Zho |
| Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications. Cancer science 2025 1 . Yuko Chikaishi, Hiroshi Matsuoka, Eiji Sugihara, Mayu Takeda, Makoto Sumitomo, Seiji Yamada, Gaku Inaguma, Yusuke Omura, Yeongcheol Cheong, Yosuke Kobayashi, Masaya Nakauchi, Junichiro Hiro, Koji Masumori, Koki Otsuka, Hiroshi Nishihara, Koichi Suda, Hideyuki Saya, Tetsuya Takimo |
- Page last reviewed:Feb 1, 2024
- Content source: